AWS powers Moderna’s digital biotechnology platform
SEATTLE — Amazon Web Services (AWS), an Amazon.com company, announced Wednesday that Moderna has selected AWS as its preferred cloud provider, as well as its standard for analytics and machine learning workloads. Leveraging its mRNA platform and manufacturing facility with the AWS-powered research engine, Moderna delivered the first clinical batch of its vaccine candidate (mRNA-1273)
